Tyrosine kinase inhibitors as antiangiogenic drugs in multiple myeloma

Domenico Ribatti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tyrosine kinase inhibitors as antiangiogenic drugs in multiple myeloma'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences